Evidence map›Paper›PMID 35416326›Full record

ReviewScandinavian journal of immunology2022

Defending and integrating an organism by the immune system.

Zlatko Dembic

Open access · hybridAbstract readReview
In one paragraph

Review in Scandinavian journal of immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Defending and integrating an organism by the immune system.Scandinavian journal of immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Zlatko DembicDepartment of Oral Biology, University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0002-9970-6497
University of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Integrity model proposes that the adaptive immune response defends, protects and keeps vigilance over the unity of an organism. These functions conceptually rely on three signals that can explain them. All signals have a dual character. The signal-1 is the recognition of antigen or peptide/MHC ligand. The signal-2 comprises either help and costimulation or suppression and coinhibition. Lastly, the signal-3 signals tissues' condition, state or integrity. A part overlaps with the Danger-associated molecular patterns, and the other part should be detected by putative cell-surface molecules, intracellular factors or epigenetic events. They are called the Integrity-associated molecular patterns (IAMPs). The IAMPs originate from damaged (positive signal-3) or undamaged (negative signal-3) tissues. The positive signal-3 would induce costimulatory signal-2, whereas the negative signal-3 would induce coinhibitory signal-2 in APCs. However, in analogue reality, we might more likely encounter a range of signals supposedly sensed by a group of responder cells and integrated overtime (quorum sensing). The predominant option would sway the decision of the immune system to perform either defence or protection (active tolerance). Thus, the quorum sensing supposedly delivers two qualitative thresholds for T (and B) cells' decisions to defend or suppress. If these were not attained, the vigilance (anergy) of adaptive immunocytes for T-dependent antigens would ensue. These functions provide defence against pathogens and preservation of unity/integrity of an organism, which in turn permits protection of commensals.

Indexed as

Immune SystemImmune ToleranceB-LymphocytesLymphocyte Activationadaptive immunityhypothesisinnate immunitynatural selection

Identifiers

PMID35416326
PMCPMC9285719
OpenAlexW4223635889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.